Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1860

Journal of Obesity & Weight Loss Therapy received 1860 citations as per Google Scholar report

Journal of Obesity & Weight Loss Therapy peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • Centre for Agriculture and Biosciences International (CABI)
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • CABI full text
  • Cab direct
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • University of Bristol
  • Pubmed
  • ICMJE
Share This Page

In pregnancies with overweight/obese gestational diabetes: Basal-bolus insulin therapy reduces maternal excessive triglyceride rise

3rd International Conference and Exhibition on Obesity & Weight Management

Pablo R Olmos

Pontificia Universidad Cat�?³lica de Chile, Chile

ScientificTracks Abstracts-Workshop: J Obes Weight Loss Ther

DOI: 10.4172/2165-7904.C1.020

Abstract
One of the mechanisms for unrelenting macrosomia in the offspring of overweight or obese mothers with glucose-controlled gestational diabetes (GDM) is an excessive rise of maternal triglycerides (TG) during pregnancy. Objectives: To ascertain if basal-bolus insulin therapy (BBIT) or other component of GDM treatment (limitation of weight gain, Metformin), were capable of reducing this excessive rise of TG in GDM. Methods: In a longitudinal-retrospective fashion, we studied 131 singleton GDM pregnancies by means of Stepwise multiple linear regression, which determined that only BBIT (p= 0.011) -and no other aspect of treatment- was related to a decrease in maternal TG Z-Scores. Thereafter, we divided the 131 GDM pregnancies in 2 groups: No-BBIT (n=58, BMI 20-24.9 Kg �?�? m-2), and BBIT (n=71, BMI â�?¥25.0 Kg �?�? m-2. We also calculated Atherogenic Index of Plasma (AIP, an indirect measure of cholesterol-ester transfer protein, CETP activity) as Log10(TG/HDL), where HDL is high-density lipoprotein cholesterol. Newly Observed Findings: [a] Only BBIT treatment -but neither limitation of weight gain nor Metformin- was capable to decrease maternal TG Z-scores, by doing so in a dose-related fashion (RSpearman=-0.221; p= 0.03). [b] The AIP remained within normal ranges for pregnancy, being similar in both groups (p=0.9). Conclusions: Basal-bolus insulin therapy reduces the excessive rise of maternal triglycerides in overweight-obese GDM mothers with tight glycemic control. This beneficial effect of insulin is not related to changes in the CETP activity.
Biography

Pablo R Olmos finished his Internal Medicine Residency in 1987, plus Endocrinology Fellowship at The Ohio State University (OSU) College of Medicine in 1993, plus a MS degree in Biomedical Engineering at OSU College of Engineering. He has published 49 papers in both national and international journals, plus 1 book and 5 book chapters.

Email: polmos@med.puc.cl

Relevant Topics
Top